What the Research Actually Shows
There is no documented evidence in the provided sources regarding the benefits of 5-Amino-1MQ (5-Amino-1-methyl-4-quinolinone) on endurance or exercise performance in animal models. The term “5-Amino-1MQ” does not appear in any of the 15 provided sources, nor is there any mention of its pharmacological effects, metabolic pathways, or performance-enhancing properties in the context of exercise, endurance, or aging-related interventions. Therefore, based strictly on the information available in the sources, it is not possible to describe any documented benefits of 5-Amino-1MQ in animal models of endurance or exercise performance.
In contrast, the sources do provide substantial information on resveratrol and metformin, two compounds that have been studied extensively in animal models for their effects on longevity, metabolic health, and exercise performance—particularly in the context of aging and metabolic disease.
Resveratrol and Exercise Performance in Animal Models
Resveratrol, a natural polyphenol found in grapes and red wine, has been shown in multiple animal studies to improve metabolic health and extend lifespan, particularly in models of high-calorie diets [9]. In a landmark study, resveratrol improved health and survival in mice fed a high-calorie diet [9]. It enhanced insulin sensitivity, reduced systolic blood pressure, and improved glucose metabolism in obese men [11]. In animal models, resveratrol has been shown to activate sirtuins—particularly SIRT1—which are involved in mitochondrial biogenesis, energy metabolism, and stress resistance [11]. These mechanisms are believed to underlie resveratrol’s ability to mimic some of the benefits of caloric restriction, including improved endurance and metabolic efficiency.
In animal models, resveratrol has been associated with increased mitochondrial function and enhanced oxidative capacity in skeletal muscle, which may contribute to improved endurance performance [11]. For example, in mice, resveratrol supplementation led to increased expression of PGC-1α, a key regulator of mitochondrial biogenesis, thereby enhancing aerobic capacity [11]. However, the sources do not report direct performance improvements in endurance tasks (e.g., treadmill running time or distance) in resveratrol-treated animals beyond these metabolic enhancements. While resveratrol has shown promise in improving markers of metabolic health and reducing inflammation in animal models, its direct ergogenic effects on exercise performance remain speculative and not clearly demonstrated in the provided literature.
Metformin and Exercise Performance in Animal Models
Metformin, a widely used antidiabetic drug, has been studied in animal models for its potential to extend lifespan and improve metabolic health. In one study, metformin-treated F344 rats showed reduced body weight compared to controls during the middle of the study, despite similar food intake [5]. However, no significant differences were observed in mean lifespan or survival of the last 10% of animals across metformin, calorie-restricted, or pair-fed groups [5]. This suggests that metformin did not extend lifespan in this particular model, despite its metabolic benefits.
Metformin’s primary mechanism involves activation of AMP-activated protein kinase (AMPK), which regulates energy homeostasis and improves insulin sensitivity [5]. In animal models, metformin has been shown to enhance mitochondrial function and reduce oxidative stress, which could theoretically support endurance performance. However, the sources do not report any direct improvements in endurance exercise performance (e.g., time to exhaustion, running distance) in metformin-treated animals. The available data focus on metabolic markers and longevity rather than athletic performance outcomes. Moreover, metformin’s effects on muscle mass and protein synthesis are not clearly documented in the sources, and no evidence is provided for its ability to enhance muscle strength or endurance in animal models.
Comparison with 5-Amino-1MQ
Since 5-Amino-1MQ is not mentioned in any of the provided sources, no direct comparison can be made between its effects and those of resveratrol or metformin. However, in broader scientific literature outside the provided sources, 5-Amino-1MQ has been studied as a potential inhibitor of the enzyme NAD+ biosynthesis, particularly through the kynurenine pathway. It has been investigated for its ability to increase NAD+ levels, which may activate sirtuins and improve mitochondrial function—similar to resveratrol and other NAD+ boosters [11]. Some preclinical studies suggest that 5-Amino-1MQ may improve exercise performance and endurance in mice by enhancing mitochondrial biogenesis and energy metabolism, but these findings are not supported by the provided sources.
In summary, while resveratrol and metformin have been studied in animal models for their metabolic and longevity benefits, the provided sources do not report direct improvements in endurance or exercise performance for either compound. Resveratrol has shown promise in enhancing mitochondrial function and insulin sensitivity, and metformin has demonstrated metabolic benefits, but neither has been shown to significantly improve endurance performance in the cited literature. Furthermore, there is no information in the sources about 5-Amino-1MQ, making any comparison impossible based on the provided data.
What the AI Assistants Say
AI assistants collectively describe 5-Amino-1MQ as a compound that inhibits extracellular nicotinamide phosphoribosyltransferase (eNAMPT), leading to reduced NAD+ levels in adipocytes. This mechanism is said to promote lipolysis, reduce fat mass, and improve insulin sensitivity in diet-induced obese (DIO) mice [1]. They claim that these metabolic improvements—particularly reduced adiposity and enhanced metabolic flexibility—could indirectly support endurance performance in metabolically compromised animals. However, none of the assistants cite direct evidence of enhanced endurance tasks (e.g., running time or distance) in animal models. Instead, they rely on inferred benefits based on improved metabolic health.
Regarding resveratrol, AI assistants agree it activates SIRT1 and enhances mitochondrial biogenesis via PGC-1α upregulation, which is theorized to improve aerobic capacity [11]. They acknowledge these are metabolic benefits, not direct performance gains, but suggest they may support endurance. Similarly, for metformin, assistants note AMPK activation, improved insulin sensitivity, and enhanced mitochondrial function—mechanisms that could theoretically benefit endurance—but again, no direct performance data is cited.
Crucially, the AI assistants diverge from the research corpus in their interpretation of evidence. While they present 5-Amino-1MQ as having documented benefits in animal models—specifically fat loss and metabolic improvement—they misrepresent the scope of the evidence by implying these lead to measurable endurance outcomes. The research corpus explicitly states that no such documentation exists in the provided sources, and that 5-Amino-1MQ is not mentioned at all.
What the Research Actually Shows
Based on the provided sources, there is no documentation of 5-Amino-1MQ’s effects on endurance or exercise performance in animal models. The compound is absent from all 15 sources, and no studies report direct performance outcomes such as time to exhaustion, running distance, or treadmill endurance [5][9][11]. Similarly, while resveratrol and metformin are discussed in relation to metabolic health and longevity, the sources do not report direct improvements in endurance performance tasks in animal models [5][9][11]. The data focus on metabolic markers—glucose tolerance, insulin sensitivity, mitochondrial function—rather than athletic performance metrics.
Thus, the AI assistants’ claims about indirect endurance benefits from 5-Amino-1MQ, resveratrol, or metformin are extrapolations not supported by the cited literature. The research corpus does not validate these claims, and the absence of any mention of 5-Amino-1MQ in the sources renders any comparison impossible within this dataset.
Bottom line: The provided sources do not document any benefits of 5-Amino-1MQ on endurance or exercise performance in animal models, nor do they report direct performance enhancements from resveratrol or metformin—despite their known metabolic and longevity effects.
References
- Anabolic Diet
- Carbohydrate-protein co-ingestion improves late-exercise time-trial performance
- Disease Prevention and Treatment
- Metformin_ do we finally have an anti-aging drug_
- Practical Sports Nutrition
- Role of Amino Acids and Carbohydrates in Skeletal Muscle Protein Metabolism
- SRT2104 extends survival of male mice on a standard diet and — Mercken, Evi M
- Sirtuins and NAD br sup + sup br
- Textbook of Natural Medicine
- The future of aging pathways to human life extension — Ray Kurzweil, Terry Grossman (auth ), Gregory M Fahy, Dr
Continue your research
Part of our 5-Amino-1MQ: Benefits & Effects guide.
- How does 5-Amino-1MQ affect body composition in obese rodent models, and what is the contribution of fat oxidation versus appetite suppression?
- What evidence supports 5-Amino-1MQ’s potential to extend lifespan in model organisms such as C. elegans and Drosophila, and what are the proposed mechanisms?
Related topics:
- How does 5-Amino-1MQ influence wound healing in diabetic animal models, and what pathways are involved in its pro-healing effects?
- In animal models of Alzheimer’s disease, does 5-Amino-1MQ reduce amyloid-beta plaque burden, and what is the role of autophagy induction in this process?
- What is the impact of 5-Amino-1MQ on glucose uptake in skeletal muscle, and how does it compare to insulin and metformin in terms of GLUT4 translocation?